Alyeska Investment Group
APLT

Alyeska Investment Group’s Applied Therapeutics APLT Stock Holding History

Alyeska Investment Group’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4,000,000
Closed -$27.2M – 566
2024
Q1 		$27.2M Sell
4,000,000
-3,500,000
-47% -$15.7M 0.17% 181
2023
Q4 		$25.1M Hold
7,500,000
– – 0.17% 171
2023
Q3 		$18.7M Hold
7,500,000
– – 0.13% 209
2023
Q2 		$9.6M Buy
7,500,000
+3,250,000
+76% +$4.31M 0.07% 270
2023
Q1 		$3.45M Buy
+4,250,000
New +$4.19M 0.03% 322
2022
Q4 		– Sell
-4,250,000
Closed -$3.95M – 415
2022
Q3 		$3.95M Buy
+4,250,000
New +$5.1M 0.05% 278

Other funds holding APLT

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Alyeska Investment Group's APLT Position: Q2 2025 in Review

Alyeska Investment Group sold out of Applied Therapeutics (APLT) in Q2 2025, closing a stake of 3,107,497 shares — an estimated $1.52M sold.

Alyeska Investment Group first reported a position in APLT in Q2 2022 and held it in 12 quarters. The position peaked at $10.5M in Q3 2023. 75 funds tracked by Wall St. Rank hold APLT as of Q2 2025.

  • Alyeska Investment Group reported no remaining Applied Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Alyeska Investment Group sold 3,107,497 Applied Therapeutics shares in Q2 2025, an estimated $1.52M.
  • Alyeska Investment Group first reported a position in Applied Therapeutics in Q2 2022 and held it in 12 quarters.
  • Alyeska Investment Group's Applied Therapeutics position peaked at $10.5M in Q3 2023.
  • 75 funds tracked by Wall St. Rank held Applied Therapeutics as of Q2 2025.

Based on Alyeska Investment Group's 13F filing for Q2 2025, filed 14 Aug 2025.